Corton Capital Inc. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 35.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,276 shares of the pharmaceutical company’s stock after selling 701 shares during the quarter. Corton […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by JPMorgan Chase & Co. from $180.00 to $170.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […]
Corton Capital Inc. lessened its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 35.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,276 shares of the pharmaceutical company’s stock after selling 701 shares during the period. Corton Capital Inc.’s holdings in Vertex Pharmaceuticals were worth $444,000 as of its most recent filing […]
Mather Group LLC. grew its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 13.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,592 shares of the pharmaceutical company’s stock after acquiring an additional 422 shares during the period. […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $26.36, but opened at $24.64. ACADIA Pharmaceuticals shares last traded at $23.85, with a volume of 261,332 shares traded. The biopharmaceutical company reported $0.28 earnings […]